733 related articles for article (PubMed ID: 32878895)
1. Loss of the Nuclear Protein RTF2 Enhances Influenza Virus Replication.
Chia BS; Li B; Cui A; Eisenhaure T; Raychowdhury R; Lieb D; Hacohen N
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878895
[TBL] [Abstract][Full Text] [Related]
2. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs.
Chen SC; Jeng KS; Lai MMC
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768860
[TBL] [Abstract][Full Text] [Related]
3. Double Plant Homeodomain Fingers 2 (DPF2) Promotes the Immune Escape of Influenza Virus by Suppressing Beta Interferon Production.
Shin D; Lee J; Park JH; Min JY
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404846
[TBL] [Abstract][Full Text] [Related]
4. Cellular 5'-3' mRNA Exoribonuclease XRN1 Inhibits Interferon Beta Activation and Facilitates Influenza A Virus Replication.
Liu YC; Mok BW; Wang P; Kuo RL; Chen H; Shih SR
mBio; 2021 Aug; 12(4):e0094521. PubMed ID: 34311580
[TBL] [Abstract][Full Text] [Related]
5. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.
Hsu SF; Su WC; Jeng KS; Lai MM
J Virol; 2015 Apr; 89(7):3671-82. PubMed ID: 25589657
[TBL] [Abstract][Full Text] [Related]
6. The Nucleolar Protein LYAR Facilitates Ribonucleoprotein Assembly of Influenza A Virus.
Yang C; Liu X; Gao Q; Cheng T; Xiao R; Ming F; Zhang S; Jin M; Chen H; Ma W; Zhou H
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209172
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of JIP4 at S730 Presents Antiviral Properties against Influenza A Virus Infection.
Del Sarto J; Gerlt V; Friedrich ME; Anhlan D; Wixler V; Teixeira MM; Boergeling Y; Ludwig S
J Virol; 2021 Sep; 95(20):e0067221. PubMed ID: 34319782
[TBL] [Abstract][Full Text] [Related]
8. PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor.
Xia C; Wolf JJ; Sun C; Xu M; Studstill CJ; Chen J; Ngo H; Zhu H; Hahm B
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915279
[TBL] [Abstract][Full Text] [Related]
9. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
10. VAMP8 Contributes to the TRIM6-Mediated Type I Interferon Antiviral Response during West Nile Virus Infection.
van Tol S; Atkins C; Bharaj P; Johnson KN; Hage A; Freiberg AN; Rajsbaum R
J Virol; 2020 Jan; 94(2):. PubMed ID: 31694946
[TBL] [Abstract][Full Text] [Related]
11. β-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-κB signaling.
Hillesheim A; Nordhoff C; Boergeling Y; Ludwig S; Wixler V
Cell Commun Signal; 2014 Apr; 12():29. PubMed ID: 24767605
[TBL] [Abstract][Full Text] [Related]
12. The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins.
Weiss CM; Trobaugh DW; Sun C; Lucas TM; Diamond MS; Ryman KD; Klimstra WB
mSphere; 2018 Sep; 3(5):. PubMed ID: 30232164
[TBL] [Abstract][Full Text] [Related]
13. LYAR Suppresses Beta Interferon Induction by Targeting Phosphorylated Interferon Regulatory Factor 3.
Yang C; Liu X; Cheng T; Xiao R; Gao Q; Ming F; Jin M; Chen H; Zhou H
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413131
[TBL] [Abstract][Full Text] [Related]
14. Cell type- and replication stage-specific influenza virus responses in vivo.
Fay EJ; Aron SL; Macchietto MG; Markman MW; Esser-Nobis K; Gale M; Shen S; Langlois RA
PLoS Pathog; 2020 Aug; 16(8):e1008760. PubMed ID: 32790753
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA hsa-miR-324-5p Suppresses H5N1 Virus Replication by Targeting the Viral PB1 and Host CUEDC2.
Kumar A; Kumar A; Ingle H; Kumar S; Mishra R; Verma MK; Biswas D; Kumar NS; Mishra A; Raut AA; Takaoka A; Kumar H
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045983
[TBL] [Abstract][Full Text] [Related]
16. Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling.
Wang Q; Pan W; Wang S; Pan C; Ning H; Huang S; Chiu SH; Chen JL
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361428
[TBL] [Abstract][Full Text] [Related]
17. Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.
Wang S; Chi X; Wei H; Chen Y; Chen Z; Huang S; Chen JL
J Virol; 2014 Aug; 88(15):8375-85. PubMed ID: 24829357
[TBL] [Abstract][Full Text] [Related]
18. PJA1 Coordinates with the SMC5/6 Complex To Restrict DNA Viruses and Episomal Genes in an Interferon-Independent Manner.
Xu W; Ma C; Zhang Q; Zhao R; Hu D; Zhang X; Chen J; Liu F; Wu K; Liu Y; Wu J
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185588
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.
Liu G; Lu Y; Liu Q; Zhou Y
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602605
[TBL] [Abstract][Full Text] [Related]
20. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
